TF Capital is an early-stage venture capital firm focused on innovative biotech and biopharmaceutical companies in China, with $1B in assets under management and a track record of 20 IPOs and $2.8B+ in license-out upfronts.
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
China
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.